A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

A Hemisphere-Separated Protocol for Morphological Observation and Combined RNA-Protein Extraction in Murine Brain Regions

71 views

⸱

DOI:

10.3791/71465

⸱

September 1st, 2026

 ,  ,  ,  ,  ,  ,  , 

* These authors contributed equally

In This Article

Summary

This protocol bisects murine brains. One hemisphere is used for morphological staining, and the other for RNA and protein extraction. The strategy decreases animal consumption, follows the 3Rs principles and minimizes inter-animal variation.

Abstract

In daily neuroscience research, morphological staining and nucleic acid/protein molecular assays typically require separate experimental animals, which increases animal use and is inconsistent with the 3Rs animal welfare principle. This protocol establishes a tissue allocation workflow for murine brain tissue that enables paired morphological and molecular analyses from a single animal. After transcardial perfusion with 0.9% saline, the brain is bisected into two hemispheres. One hemisphere is fixed in 4% paraformaldehyde for immunohistochemistry and immunofluorescence; sections stored in a sucrose-ethylene glycol-polyvinylpyrrolidone (PVP) solution maintain reliable staining quality for up to seven years. The contralateral hemisphere is cryopreserved at -80 °C for combined RNA and protein extraction, with yields sufficient for downstream qPCR and Western Blot. Tested on 9–10 mg entorhinal cortex punches, this method produces lower RNA and protein yields than separate extraction of RNA or protein individually, yet the recovered biomolecules remain adequate for molecular detection. This workflow lowers animal consumption and removes inter-individual differences between paired morphological and molecular analyses. It provides a feasible tissue preparation method for multidimensional profiling of discrete murine brain subregions.

Introduction

Neuroscience research has expanded dramatically over recent decades, uncovering key mechanisms governing human brain physiology, neurological disease onset, and therapeutic development. Animal models remain indispensable for neuroscientific inquiry, providing controllable, reproducible platforms to explore neural development, physiological function, and pathological processes. Experimental manipulation and histological observation in murine subjects allow researchers to characterize neuronal signaling, neural circuit formation, and neural-behavioral associations. Parallel to technical progress, animal experimental ethics has become a central concern. The 3Rs principles (Replacement, Reduction, and Refinement) are now globally accepted standards for all animal studies1,2, requiring researchers to minimize animal use while maintaining reliable experimental outcomes.

Innovative tools such as conditional knockout systems permit precise genetic manipulation within discrete subregions of the murine brain3. These advances have fueled intensive research into microscale brain compartments, such as hippocampal CA1, CA3, and DG, that regulate learning, memory, and mood4. Decoding the high-order functions of these tiny brain regions demands coordinated morphological, transcriptional, and protein-level measurements. Unfortunately, their scarce tissue volume creates major technical obstacles for parallel multi-index detection.

Morphological staining, RNA quantification, and protein immunodetection are three routine core readouts in neuroscience. Traditional research designs require three separate cohorts of murine animals to complete these three types of testing. This practice drastically increases animal expenditure and introduces considerable inter-animal biological variation, which weakens comparability between histological and molecular datasets. A unified workflow that acquires matched morphological and molecular signals from one single animal would greatly address these two critical limitations and better comply with the Reduction principle of the 3Rs.

Here, we report a reproducible hemispheric separation protocol for murine brain tissue. After systemic saline perfusion, the whole brain is divided into two hemispheres: one hemisphere is fixed for morphological examinations, and the contralateral hemisphere is cryopreserved for simultaneous RNA and protein co-extraction. Tissues fixed and stored in sucrose-ethylene glycol-polyvinylpyrrolidone (PVP) protective buffer maintain stable, high-quality staining signals for immunohistochemistry and immunofluorescence for up to seven years. We validated this method using tiny 9–10 mg punches of the entorhinal cortex, tissue lighter than commonly investigated regions such as the hippocampus and prefrontal cortex. The successful detection of this minute tissue sample indicates that smaller brain subregions such as the hypothalamus and amygdala are also compatible with this workflow. Although the protocol generates lower RNA and protein concentrations than specialized single-purpose extraction kits, the isolated biomolecules possess adequate quality to support standard downstream qPCR and Western blot analysis. This workflow lowers animal consumption and removes inter-individual differences between paired morphological and molecular analyses. It provides a feasible tissue preparation method for multidimensional profiling of discrete murine brain subregions.

Access restricted. Please log in or start a trial to view this content.

Protocol

Ethics statement

All animal experiments performed in this study were approved by the Institutional Animal Care and Use Committee of Dalian Medical University (Approval No. AEE18026 for rat experiments and No. AEE24261 for mouse experiments), People’s Republic of China. All experimental protocols were implemented in accordance with the ethical guidelines for laboratory animals and fully complied with the 3Rs principles (Reduction, Replacement, and Refinement) for animal experimentation. Throughout the entire experimental process, rigorous measures were adopted to effectively alleviate animal suffering and distress. Meanwhile, the number of experimental animals was limited to the minimum quantity required to ensure the reliability and validity of statistical analysis results. See the Table of Materials for a complete list of reagents, consumables, and equipment used in this protocol.

1. Experimental animal preparation and transcardial perfusion surgery

  1. Anesthesia and pre-operative preparation
    1. Use specific-pathogen-free (SPF) grade adult male Sprague-Dawley rats or C57BL/6 mice for this protocol. House the animals in a temperature-controlled (22 ± 2 °C) environment with a 12 h light/dark cycle. Provide the animals with ad libitum access to sterile food and water.
    2. Administer sodium pentobarbital to animals via intraperitoneal injection at a dose of 80 mg/kg for rats or 50 mg/kg for mice to induce anesthesia (see Figure 1).
  2. Transcardial perfusion procedure
    1. Fix the anesthetized animals in the supine position on a surgical board.
    2. Cut open the abdominal wall along the midline from the xiphoid process to the pubic symphysis using straight scissors. Cut the lateral thoracic wall bilaterally to fully expose the heart.
    3. Perfuse the animal with ice-cold 0.9% normal saline at a constant flow rate: 100–150 mL over 10–15 min for rats and 20–30 mL over 5–8 min for mice.
  3. Brain harvesting and hemisphere separation
    1. Decapitate the animals with large surgical scissors after perfusion completion. Cut the scalp along the midline to expose the skull.
    2. Use a sterile spatula to gently lift the brain from the cranial cavity. Rapidly transfer the whole brain to a sterile Petri dish placed on ice.
    3. Use a sterile, RNase-free razor blade to symmetrically divide the brain into left and right hemispheres along the sagittal suture.
    4. Immediately transfer the left hemisphere to a 15 mL centrifuge tube containing 10 mL of ice-cold 4% paraformaldehyde solution for fixation. Transfer the right hemisphere to a labeled, RNase-free cryopreservation tube, snap-freeze it in liquid nitrogen, and store it at -80 °C until RNA and protein extraction.

2. Brain tissue fixation, sectioning, and long-term storage

  1. Fixation and dehydration
    1. Fully immerse the left hemisphere in 4% paraformaldehyde solution and fix the tissue at 4 °C for 24 h. Transfer the brain hemisphere to a 15 mL centrifuge tube containing 30% sucrose solution after completion of fixation, and dehydrate the tissue at 4 °C.
    2. Replace the 30% sucrose solution every 24 h until the brain tissue sinks to the bottom of the tube.
  2. Cryosection preparation
    1. Remove the dehydrated brain hemisphere from the sucrose solution and gently blot excess liquid with sterile filter paper.
    2. Mount the brain hemisphere on the cryostat specimen stage with optimal cutting temperature (OCT) embedding medium.
    3. Cut serial coronal brain sections at a thickness of 30 µm using a cryostat. Collect consecutive sections in a 24-well plate containing sterile 0.01 M PBS.
  3. Long-term storage of brain sections
    1. Prepare the brain slice cryoprotectant preservation solution in advance: Add 2 g of PVP400, 60 g of sucrose, and 60 mL of ethylene glycol to 100 mL of 0.01 M PBS. Stir the solution at room temperature until all components are fully dissolved and store it at 4 °C until use.

3. RNA extraction with TRIzol

  1. Tissue homogenization and phase separation
    1. Homogenize the entorhinal cortical tissue in 1 mL of TRIzol reagent using an ultrafine homogenizer and incubate the homogenate on ice for 15 min. Centrifuge at 8,000 × g for 5 min at 4 °C.
    2. Add 200 µL of chloroform and vortex for 10 s. Centrifuge at 5,600 × g for 15 min at 4 °C. Then transfer the upper aqueous phase to an RNase-free tube. Add 500 µL of isopropanol and incubate at -20 °C overnight to precipitate RNA. Centrifuge again.
  2. RNA precipitation, washing, and quality assessment
    1. Discard the supernatant and wash the RNA pellet with 1 mL of 75% ethanol. Centrifuge at 5,600 × g for 5 min at 4 °C. Remove the supernatant, air-dry the pellet for 10 min, and dissolve the RNA in 20 µL of DEPC-treated water for 10 min.
    2. Measure RNA concentration and purity (A260/A280) using a spectrophotometer. Store the RNA at -80 °C until further analysis.

4. Total protein extraction with Minute kit

  1. Tissue lysis and homogenization
    1. Pre-chill the spin column and collection tube on ice. Homogenize the tissue in 100 µL of cell lysis buffer using an ultrafine homogenizer. Rinse the homogenizer with an additional 100 µL of cell lysis buffer and combine the lysates.
  2. Protein recovery and quantification
    1. Transfer the homogenate to the spin column and incubate for 2 min at room temperature.
    2. Centrifuge at 11,000–14,300 × g for 2 min.
    3. Place the collection tube on ice immediately after centrifugation and discard the spin column. Determine protein concentration using a BCA assay.

5. Simultaneous RNA and protein extraction from entorhinal cortex (9–10 mg)

  1. Pre-experiment preparation and reagent preparation
    1. Use the DNA/RNA/protein kit for all extraction steps. Use only certified RNase-free and DNase-free consumables (see Figure 2).
    2. Prepare the lysis buffer immediately before use: Add protease inhibitor cocktail to the kit-provided lysis buffer at a 1:100 dilution.
  2. Tissue lysis and phase separation
    1. Remove the frozen right brain hemisphere from -80 °C storage and place it on ice. Use a sterile RNase-free punch to collect 9–10 mg of tissue from the target brain region.
    2. Homogenize the tissue fully on ice using an electric tissue homogenizer until no visible tissue fragments remain. Incubate the homogenate on ice for 10 min to ensure complete lysis.
    3. Add 200 µL of the kit-provided separation reagent to the homogenate. Vortex the tube vigorously for 30 s and incubate it at room temperature for 3 min. Centrifuge the tube at 8,000 × g for 15 min at 4 °C to achieve complete phase separation.
  3. RNA purification and elution
    1. Carefully collect the upper aqueous phase using an RNase-free pipette tip. Transfer the collected aqueous phase to a new 1.5 mL RNase-free tube. Add an equal volume of 100% ethanol to the collected aqueous phase and mix.
    2. Transfer 700 µL of the mixture to the kit-provided RNA purification column. Centrifuge the column at 5,600 × g for 1 min at room temperature.
    3. Add 500 µL of the kit-provided RNA wash buffer 1 to the column. Centrifuge the column at 5,600 × g for 1 min at room temperature.
    4. And add 500 µL of kit-provided RNA wash buffer 2 to the column, centrifuge again. Centrifuge the empty column at 8,000 × g for 2 min at room temperature to completely remove residual ethanol from the column membrane.
    5. Transfer the column to a new RNase-free 1.5 mL microcentrifuge tube. Add 30–50 µL of RNase-free water (preheated to 60 °C) directly to the center of the column membrane. Incubate the column at room temperature for 2 min. Centrifuge the column at 8,000 × g for 1 min at room temperature to elute the RNA.
  4. Protein precipitation and dissolution
    1. Add 750 µL of isopropanol to the remaining organic phase and interphase in the original tube after removing the aqueous phase for RNA extraction. Incubate the mixture at -20 °C for 30 min to precipitate proteins.
    2. Centrifuge the tube at 8,000 × g for 10 min at 4 °C. Discard the supernatant and keep the protein pellet intact at the bottom of the tube.
    3. Add 1 mL of 95% ethanol to the protein pellet. Vortex the tube briefly to wash the pellet. Centrifuge the tube at 8,000 × g for 5 min at 4 °C and discard the supernatant. Repeat this wash step two more times.
    4. Air-dry the protein pellet at room temperature for 5–10 min until the pellet becomes translucent and no residual ethanol is visible.
    5. Add 50–100 µL of 5–10% SDS solution to the dried pellet. Vortex the tube vigorously for 1 min and incubate it on ice for 10 min to fully dissolve the protein. Centrifuge the tube at 8,000 × g for 5 min at 4 °C. Collect the supernatant as the final protein extract.

6. Immunohistochemistry (IHC) staining

  1. Section pre-treatment and endogenous enzyme inactivation
    1. Remove brain sections from -20 °C cryoprotectant storage. Use a glass needle to transfer the sections to a 24-well plate containing 0.01 M PBS (pH 7.4).
    2. Wash the sections three times with 0.01 M PBS, 5 min per wash, at room temperature on a shaker.
    3. Incubate the sections with 3% hydrogen peroxide peroxidase blocker at room temperature for 10 min to inactivate endogenous peroxidase activity. Repeat the washing steps after blocking.
  2. Permeabilization and non-specific blocking
    1. Incubate the sections in 0.5% Triton X-100 for 30 min at room temperature on a shaker for cell membrane permeabilization. Repeat the washing steps.
    2. Incubate the sections in 4% bovine serum albumin for 30 min at room temperature, followed by incubation with a non-specific staining inhibitor for an additional 30 min at room temperature.
  3. Primary and secondary antibody incubation
    1. Dilute primary antibodies in 1% BSA solution at the following optimized dilutions: doublecortin (DCX, 1:4000), neuronal nuclear antigen (NeuN, 1:3000), ionized calcium-binding adapter molecule 1 (Iba-1, 1:2000), and glial fibrillary acidic protein (GFAP, 1:2000).
    2. Add 200 µL of diluted primary antibody solution to each well, ensuring full immersion of the sections.
    3. Add 200 µL of biotin-labeled secondary antibody to each well. Incubate the sections at room temperature for 30 min.
    4. Wash the sections three times with 0.01 M PBS, 5 min per wash. Add 300 µL of streptavidin-peroxidase conjugate to each well. Incubate the sections at room temperature for 30 min. Repeat the washing steps after incubation.
  4. 3,3′-Diaminobenzidine (DAB) chromogenic development and cover slipping
    1. Add 200 µL of DAB working solution to each well. Monitor the chromogenic reaction under a light microscope.
    2. Mount the sections onto gelatin-coated glass slides using a glass needle. Air-dry the slides completely at room temperature.
    3. Dehydrate the slides through a graded ethanol series (50%, 70%, 90%, 95%, 100%, 100% ethanol, 5 min each), followed by clearance in xylene two times, 5 min each.

7. Immunofluorescence (IF) staining

  1. Section pre-treatment and permeabilization
    1. Remove brain sections from -20 °C cryoprotectant storage. Transfer the sections to a 24-well plate containing 0.01 M PBS (pH 7.4).
    2. Wash the sections three times with 0.01 M PBS, 5 min per wash, at room temperature on a shaker.
    3. Incubate the sections in 0.5% Triton X-100 for 30 min at room temperature on a shaker.
    4. Wash the sections three times with 0.01 M PBS, 10 min per wash, after permeabilization.
  2. Blocking and primary antibody incubation
    1. Incubate the sections in a blocking solution containing 4% BSA and a non-specific staining inhibitor for 1 h at room temperature in a humidified chamber.
    2. Aspirate the blocking solution. Dilute primary antibodies in 1% BSA solution at optimized concentrations and add 300 µL of the diluted primary antibody solution to each well. Incubate the sections overnight at 4 °C in a humidified, light-proof chamber.
  3. Secondary antibody incubation
    1. Rewarm the sections at room temperature for 1 h in the dark the next day. Recover the primary antibody solution and wash the sections three times with 0.01 M PBS, 10 min per wash, on a shaker in the dark.
    2. Dilute fluorophore-conjugated secondary antibodies in 1% BSA solution at the manufacturer's recommended dilution. Add 300 µL of the secondary antibody solution to each well. Incubate the sections at room temperature for 1–2 h in the dark.
    3. Wash the sections five times with 0.01 M PBS, 5 min per wash, in the dark.

8. Quantitative real-time PCR (qPCR) analysis

  1. RNA gDNA removal and reverse transcription
    1. Perform reverse transcription to synthesize cDNA using a reverse transcription kit, with 1 µg of total RNA per 20 µL reaction system. Use the manufacturer's recommended thermal cycling program: 25 °C for 5 min, 50 °C for 15 min, 85 °C for 5 min, hold at 4 °C.
    2. Dilute the synthesized cDNA 1:5 with RNase-free water. Store the cDNA at -20 °C until qPCR amplification.
  2. qPCR system preparation and amplification
    1. Prepare the qPCR reaction system on ice in a dedicated RNase-free PCR hood. The 20 µL reaction system includes: 10 µL of qPCR Master Mix, 0.4 µL of forward primer (10 µM), 0.4 µL reverse primer (10 µM), 2 µL of diluted cDNA template, 7.2 µL of RNase-free water.
    2. Perform qPCR amplification using the following program: 95 °C for 30 s of initial denaturation; 40 cycles of 95 °C for 10 s and 60 °C for 30 s; followed by dissociation curve analysis from 60 °C to 95 °C, with 0.5 °C increments per 5 s.

9. Western blot

  1. Protein quantification and sample preparation
    1. Dilute the protein extracts to equal concentrations using 5–10% SDS solution, based on the BCA assay results.
  2. SDS-PAGE electrophoresis and protein transfer
    1. Prepare a 10% SDS-PAGE separating gel and a 5% stacking gel according to standard molecular biology protocols.
    2. Load 20 µg of total protein per well into the gel. For gradient loading experiments, load 15 µg, 30 µg, and 45 µg of protein per well.
    3. Perform electrophoresis at 80 V for 30 min until the protein marker enters the separating gel, then increase the voltage to 120 V for 60–90 min until the bromophenol blue dye reaches the bottom of the gel.
    4. Assemble the transfer sandwich in the following order (from cathode to anode): sponge, filter paper, gel, PVDF membrane, filter paper, and sponge. Ensure that no air bubbles remain between the gel and the membrane.
    5. Perform wet transfer at 300 mA constant current for 90 min in an ice bath.
  3. Membrane blocking and antibody incubation
    1. Rinse the PVDF membrane briefly with TBST buffer after transfer completion. Incubate the membrane in 5% BSA for 2 h at room temperature on a shaker to block non-specific binding sites.
    2. Dilute primary antibodies in 5% BSA solution at optimized concentrations. Incubate the membrane with the primary antibody solution overnight at 4 °C on a shaker.
    3. Wash the membrane three times with TBST buffer, 10 min per wash, on a shaker the next day.
    4. Dilute horseradish peroxidase (HRP)-conjugated secondary antibody in 5% non-fat milk solution at the manufacturer's recommended dilution. Incubate the membrane with the secondary antibody solution for 2 h at room temperature on a shaker.
    5. Wash the membrane three times with TBST buffer, 10 min per wash, after secondary antibody incubation. Incubate the membrane with the ECL substrate solution for 1–2 min in the dark.

Access restricted. Please log in or start a trial to view this content.

Results

Assessment of RNA concentration, agarose gel electrophoresis, and qPCR

As shown, total RNA and protein were co-extracted from entorhinal cortex (9–10 mg) punches with the DNA/RNA/protein kit. Parallel samples processed with TRIzol (RNA) or the protein extraction kit served as controls. The protocol yielded 235 ± 12 ng µL⁻1 RNA, 36 % less than TRIzol (p < 0.05) (Figure 3A). Nevertheless, agarose gels revealed sharp 28S and 18...

Access restricted. Please log in or start a trial to view this content.

Discussion

In murine research, morphological analyses and nucleic acid/protein assays often require separate animal samples because of their distinct preparation procedures. This increases animal use and introduces inter-animal biological variation, which may reduce comparability between histological and molecular datasets. To address these limitations, we developed a workflow that enables histological and molecular data to be obtained from the same animal.

The central design of this workflow is the hemi...

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors declare that they have no known competing financial interests or personal relationships that could have influenced the work reported in this paper.

Acknowledgements

This work was supported by grants from the Education Department of Liaoning Province (General Research Project JYTMS20230571) and Dalian Medical University’s 2023 “Integrated Traditional Chinese and Western Medicine for Health and Wellness” initiative (H0.2XY2023KY10), both awarded to Prof. CQ Liu; and by the 2025 Liaoning Province Undergraduate Innovation & Entrepreneurship Training Program(S202510161061) and Dalian Medical University’s Undergraduate Innovative Talent Training and Teaching Reform Fund (112307010209), both awarded to YK Li.

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
1.5 mL RNase-free microcentrifuge tubesAxygenMCT-150-C-SCollection of tissue punches and RNA/protein extraction fractions.
15 mL conical centrifuge tubesBiofilCFT010150Fixation, sucrose dehydration, and solution storage.
24-well cell culture platesNEST702001Collection, staining, and long-term storage of free-floating brain sections.
30% sucrose solutionPrepared in laboratoryN/ACryoprotection of fixed brain hemispheres before cryosectioning.
4% paraformaldehyde solutionBiosharpBL539AImmersion fixation of the morphology-designated brain hemisphere.
5× protein loading bufferBeyotime BiotechnologyDL101Preparation of protein samples for SDS-PAGE.
AgaroseSolarbioCat: A8201RNA integrity assessment by agarose gel electrophoresis.
Anti-doublecortin antibodyAbcamab18723Primary antibody for doublecortin immunohistochemistry.
Anti-ERK antibodyBeyotimeAB2014Primary antibody for total ERK Western blotting.
Anti-GFAP antibodyAbcamab10062Primary antibody for glial fibrillary acidic protein immunofluorescence.
Anti-Iba1 antibodyWakoNCNP24Primary antibody for ionized calcium-binding adaptor molecule 1 immunofluorescence.
Anti-NeuN antibodyMilliporeA60Primary antibody for neuronal nuclear antigen staining.
Anti-NF-κB p65 antibodyHUABIOET1603-12Primary antibody for NF-κB p65 Western blotting.
Anti-phospho-ERK antibodyBeyotimeET1610-13Primary antibody for phosphorylated ERK Western blotting.
Anti-PSD95 antibodyHUABIOET1602-20Primary antibody for PSD95 Western blotting.
Anti-ULK1 antibodyHUABIOET1704-63Primary antibody for ULK1 Western blotting.
Anti-β-tubulin antibodyABclonalAC021Loading-control primary antibody for Western blotting.
Antifade fluorescence mounting mediumBeyotimeP0126-5Mounting medium for immunofluorescence-stained sections.
Biotin-streptavidin peroxidase detection kitFuzhou Maixin Biotech Co., Ltd.KIT-9720Secondary detection system for DAB immunohistochemistry.
Bovine serum albuminQiansheng Biotech Co., Ltd.QO3000Blocking buffer for immunostaining and Western blotting.
C57BL/6 miceLiaoning Changsheng Biotechology Co.,LTD4-week-old C57BL/6 miceExperimental animals for mouse brain tissue collection, if included.
Chemiluminescence imaging systemClinx Science Instruments Co., Ltd.ChemiScope 6200 TouchDetection of Western blot chemiluminescent signals.
Confocal laser scanning microscopeLeica Microsystems CMS GmbHSN: 591974Image acquisition for immunofluorescence sections.
Cryoprotectant preservation solutionPrepared in laboratoryN/ALong-term storage of free-floating brain sections at −20 °C.
CryostatLeicaCM1950Preparation of 30 μm coronal brain sections.
DAB chromogenic substrate kitSigmaSLBP7387VChromogenic development for immunohistochemistry.
DAPI nuclear staining solutionCoolaberSL7100Nuclear counterstain for immunofluorescence.
Digital light microscopeNingbo Yongxin Optics Co., Ltd.Model NE910+FL-900Monitoring DAB development and imaging bright-field-stained sections.
DNase IVazymeR223-01Removal of residual genomic DNA before reverse transcription.
Donkey anti-rabbit IgG, 488-conjugatedThermo Fisher ScientificA21206Fluorescent secondary antibody for immunofluorescence.
Donkey anti-rabbit IgG, 594-conjugatedAbcamab150076Fluorescent secondary antibody for immunofluorescence.
E.Z.N.A. DNA/RNA/Protein KitOmega Bio-TekD3892-01
Electrophoresis power supplyBio-Rad1645050Power supply for agarose gel electrophoresis and SDS-PAGE.
Ethylene glycolSinopharm Chemical Reagent Co.Ltd.10009828Component of cryoprotectant preservation solution.
Gel imaging systemClinx Science Instruments Co., Ltd.ChemiScope 6200 TouchImaging of agarose gels for RNA quality evaluation.
Gelatin-coated glass slidesCITOTEST LABWARE MANUFACTURING CO.,LTDREF: 10127105P P/N: 80312-2101Mounting DAB-stained free-floating brain sections.
Image analysis softwareNational Institutes of HealthImageJ/FijiDensitometric analysis of Western blot bands and image processing.
IsopropanolSinopharm Chemical Reagent Co.Ltd.80109218Protein precipitation from the organic/interphase fraction.
Microcentrifuge, refrigeratedYancheng Kaite Laboratory Instrument Co., Ltd.TGL16MCentrifugation during RNA/protein extraction and washing steps.
Minute Protein Extraction KitInventMS-026
Neutral balsam mounting medium Shanghai Yuanye Bio-Technology Co., Ltd., Shanghai, ChinaCatalog No. S30509, CAS 96949-21-2Coverslipping of dehydrated DAB-stained sections.
OCT embedding mediumSakura4583Embedding medium for cryosectioning fixed brain hemispheres.
Optical qPCR plates or tubesAxygenPCR-0208-CReaction vessels for qPCR amplification.
ParafilmamcorPM996Sealing multiwell plates for long-term section storage.
Pentobarbital sodiumHualan Bio57-33-0Anesthetic agent before transcardial perfusion.
Petri dishesBiosharpBS-90-DOn-ice brain handling and hemisphere separation.
Phenol/guanidinium RNA extraction reagentSparkladeAC0101-BComparator reagent for RNA extraction control experiments.
Phosphatase inhibitor cocktailAPExBIOK1015-100Preservation of phosphorylation during protein extraction.
Phosphate-buffered salineBiosharpBL601AWashing buffer, sucrose solution solvent, and cryoprotectant solvent.
Polyvinylidene fluoride membraneMilliporeIPVH08100Membrane for Western blot transfer.
Polyvinylpyrrolidone K40Sigma9003-39-8Component of cryoprotectant preservation solution.
Protease inhibitor cocktailBeyotimeP1045Prevention of protein degradation during tissue lysis.
Protein extraction kitInventMS-026Comparator kit for total protein extraction control experiments.
Real-time PCR systemAmolarrayMA6000Quantitative PCR amplification and melt-curve analysis.
Sodium dodecyl sulfateBioFroxx3250GR500Protein pellet dissolution and SDS-PAGE sample preparation.
Sterile razor bladesBiosharpBS-RB-11Hemisphere separation and tissue trimming on ice.
Streptavidin-peroxidase conjugateFuzhou Maixin Biotech Co., Ltd.KIT-9720Signal amplification/detection reagent for DAB immunohistochemistry.
SucroseHushi57-50-1Cryoprotection solution and cryoprotectant preservation solution.
SYBR qPCR master mixVazymeQ711-02Quantitative PCR amplification.
Transfer apparatusBio-Rad1703930Wet transfer of proteins from SDS-PAGE gel to membrane.
Tris-buffered saline with Tween 20Prepared in laboratoryN/AWestern blot membrane washing buffer.
Triton X-100Sinopharm9002-93-1Permeabilization of brain sections for immunostaining.
TrizolSparkladeAC0101-B
UltraSensitive SP Immunohistochemistry Detection Kit (for mouse/rabbit primary antibody)Fuzhou Maixin Biotech Co., Ltd.KIT-9720Secondary antibody/detection reagent for DAB immunohistochemistry.
Wistar ratLiaoning Changsheng Biotechology Co.,LTD280-320 g, maleExperimental animals for rat brain tissue collection, if included.
XyleneSinopharm Chemical Reagent Co.Ltd.10023418Clearing of DAB-stained slides before coverslipping.
Neutral balsam mounting medium Shanghai Yuanye Bio-Technology Co., Ltd., Shanghai, ChinaCatalog No. S30509, CAS 96949-21-2Coverslipping of dehydrated DAB-stained sections.
Streptavidin-peroxidase conjugateFuzhou Maixin Biotech Co., Ltd.KIT-9720Signal amplification/detection reagent for DAB immunohistochemistry.
Triton X-100Sinopharm9002-93-1Permeabilization of brain sections for immunostaining.
UltraSensitive SP Immunohistochemistry Detection Kit (for mouse/rabbit primary antibody)Fuzhou Maixin Biotech Co., Ltd.KIT-9720Secondary antibody/detection reagent for DAB immunohistochemistry.
XyleneSinopharm Chemical Reagent Co.Ltd.10023418Clearing of DAB-stained slides before coverslipping.

References

  1. Lauwereyns J, et al. Toward a common interpretation of the 3Rs principles in animal research. Lab Anim. 2024;53(12):347-50.
  2. Hubrecht RC, Carter E. The 3Rs and humane experimental technique: implementing change. Animals (Basel). 2019;9(10):754.
  3. Gavériaux-Ruff C, Kieffer BL. Conditional gene targeting in the mouse nervous system: Insights into brain function and diseases. Pharmacol Ther. 2007;113(3):619-34.
  4. Basu J, Siegelbaum SA. The corticohippocampal circuit, synaptic plasticity, and memory. Cold Spring Harb Perspect Biol. 2015;7(11):a021733.
  5. Wu J, et al. Transcardiac perfusion of the mouse for brain tissue dissection and fixation. Bio Protoc. 2021;11(5):e3988.
  6. Taves MD, et al. Steroid concentrations in plasma, whole blood and brain: Effects of saline perfusion to remove blood contamination from brain. PLoS One. 2010;5(12):e15727.
  7. Jordan JT. The rodent hippocampus as a bilateral structure: A review of hemispheric lateralization. Hippocampus. 2020;30(3):278-92.
  8. Mundorf A, Ocklenburg S. Looking at both sides: Integrating data from both hemispheres is crucial in rodent neuroscience. Eur J Neurosci. 2025;62(5):e70249.
  9. Watson RE, et al. Use of cryoprotectant to maintain long-term peptide immunoreactivity and tissue morphology. Peptides. 1986;7(1):155-9.
  10. Hoffman GE, Le WW. Just cool it! Cryoprotectant anti-freeze in immunocytochemistry and in situ hybridization. Peptides. 2004;25(3):425-31.
  11. Rajput SK, et al. A column-based rapid method for the simultaneous isolation of DNA, RNA, miRNA and proteins. Cell Biol Int. 2012;36(9):779-83.
  12. Morse SMJ, Shaw G, Larner SF. Concurrent mRNA and protein extraction from the same experimental sample using a commercially available column-based RNA preparation kit. Biotechniques. 2006;40(1):54-8.
  13. Puchades M, Westman A, Blennow K, Davidsson P. Removal of sodium dodecyl sulfate from protein samples prior to matrix-assisted laser desorption/ionization mass spectrometry. Rapid Commun Mass Spectrom. 1999;13(5):344-9.
  14. Kachuk C, Stephen K, Doucette A. Comparison of sodium dodecyl sulfate depletion techniques for proteome analysis by mass spectrometry. J Chromatogr A. 2015;1418:158-66.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Hemisphere SeparationMorphological StainingImmunohistochemistryImmunofluorescenceTissue AllocationBrain CryopreservationWestern BlotqPCR Analysis

This article has been published

Video Coming Soon